162 related articles for article (PubMed ID: 36248341)
1. USO1 expression is dysregulated in non-small cell lung cancer.
Keogh A; Ryan L; Nur MM; Baird AM; Nicholson S; Cuffe S; Fitzmaurice GJ; Ryan R; Young VK; Finn SP; Gray SG
Transl Lung Cancer Res; 2022 Sep; 11(9):1877-1895. PubMed ID: 36248341
[TBL] [Abstract][Full Text] [Related]
2. USO1 isoforms differentially promote liver cancer progression by dysregulating the ER-Golgi network.
Yoon S; Choi JH; Shah M; Kwon SM; Yang J; Park YN; Wang HJ; Woo HG
Carcinogenesis; 2021 Oct; 42(9):1208-1220. PubMed ID: 34293111
[TBL] [Abstract][Full Text] [Related]
3. A novel all-trans retinoic acid derivative regulates cell cycle and differentiation of myelodysplastic syndrome cells by USO1.
Li S; Deng G; Su J; Wang K; Wang C; Li L; Song S; Peng X; Chen F
Eur J Pharmacol; 2021 Sep; 906():174199. PubMed ID: 34058203
[TBL] [Abstract][Full Text] [Related]
4. Specific membrane recruitment of Uso1 protein, the essential endoplasmic reticulum-to-Golgi tethering factor in yeast vesicular transport.
Noda Y; Yamagishi T; Yoda K
J Cell Biochem; 2007 Jun; 101(3):686-94. PubMed ID: 17192843
[TBL] [Abstract][Full Text] [Related]
5. Lentivirus-mediated silencing of USO1 inhibits cell proliferation and migration of human colon cancer cells.
Sui J; Li X; Xing J; Cao F; Wang H; Gong H; Zhang W
Med Oncol; 2015 Aug; 32(8):218. PubMed ID: 26184508
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of Uso1 membrane tether reveal an alternative conformation in the globular head domain.
Heo Y; Yoon HJ; Ko H; Jang S; Lee HH
Sci Rep; 2020 Jun; 10(1):9544. PubMed ID: 32533038
[TBL] [Abstract][Full Text] [Related]
7. Expression, Prognosis and Gene Regulation Network of NFAT Transcription Factors in Non-Small Cell Lung Cancer.
Ma J; Du R; Huang Y; Zhong W; Gui H; Mao C; Song X; Lu J
Pathol Oncol Res; 2021; 27():529240. PubMed ID: 34257525
[TBL] [Abstract][Full Text] [Related]
8. Uso1 protein contains a coiled-coil rod region essential for protein transport from the ER to the Golgi apparatus in Saccharomyces cerevisiae.
Seog DH; Kito M; Yoda K; Yamasaki M
J Biochem; 1994 Dec; 116(6):1341-5. PubMed ID: 7706227
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics and prognostic significance of HDAC11 protein expression in non-small cell lung cancer: a retrospective study.
Lu D; Ma Z; Huang D; Zhang J; Li J; Zhi P; Zhang L; Feng Y; Ge X; Zhai J; Jiang M; Zhou X; Simone CB; Neal JW; Patel SR; Yan X; Hu Y; Wang J
Transl Lung Cancer Res; 2022 Jun; 11(6):1119-1131. PubMed ID: 35832445
[TBL] [Abstract][Full Text] [Related]
10. USO1 promotes tumor progression via activating Erk pathway in multiple myeloma cells.
Jin Y; Dai Z
Biomed Pharmacother; 2016 Mar; 78():264-271. PubMed ID: 26898451
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the prognostic and diagnostic values of ALKBH family members in non-small cell lung cancer.
Wang L; Feng X; Jiao Z; Gan J; Meng Q
Pathol Res Pract; 2022 Mar; 231():153809. PubMed ID: 35180653
[TBL] [Abstract][Full Text] [Related]
12. LINC00628 is differentially expressed between lung adenocarcinoma and squamous cell carcinoma and is associated with the prognosis of NSCLC.
Liu T; Xu S; Liu X
Oncol Lett; 2022 Feb; 23(2):55. PubMed ID: 34992687
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of IGFL1 indicates unfavorable prognosis in lung adenocarcinoma through promotion of cell proliferation and inhibition of apoptosis.
Wang Z; Liang X; Wang X; Yu Q
Pol J Pathol; 2021; 72(4):283-295. PubMed ID: 35308001
[TBL] [Abstract][Full Text] [Related]
14. Rewiring a Rab regulatory network reveals a possible inhibitory role for the vesicle tether, Uso1.
Yuan H; Davis S; Ferro-Novick S; Novick P
Proc Natl Acad Sci U S A; 2017 Oct; 114(41):E8637-E8645. PubMed ID: 28973856
[TBL] [Abstract][Full Text] [Related]
15. Expression signature, prognosis value and immune characteristics of cathepsin F in non-small cell lung cancer identified by bioinformatics assessment.
Song L; Wang X; Cheng W; Wu Y; Liu M; Liu R; Zhang S; Xia H; Liu H; Tai X; Zhao H; Li X; Ji F
BMC Pulm Med; 2021 Dec; 21(1):420. PubMed ID: 34923982
[TBL] [Abstract][Full Text] [Related]
16. High expression of SLC6A10P contributes to poor prognosis in lung adenocarcinoma.
Yuan K; Gao ZJ; Yuan WD; Yuan JQ; Wang Y
Int J Clin Exp Pathol; 2018; 11(2):720-726. PubMed ID: 31938158
[TBL] [Abstract][Full Text] [Related]
17. Focused CRISPR-Cas9 genetic screening reveals USO1 as a vulnerability in B-cell acute lymphoblastic leukemia.
Jaiswal AK; Truong H; Tran TM; Lin TL; Casero D; Alberti MO; Rao DS
Sci Rep; 2021 Jun; 11(1):13158. PubMed ID: 34162911
[TBL] [Abstract][Full Text] [Related]
18. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Liu X; Chen L; Zhang T
Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
[TBL] [Abstract][Full Text] [Related]
19. Skp2 expression has different clinicopathological and prognostic implications in lung adenocarcinoma and squamous cell carcinoma.
Zhong K; Yang F; Han Q; Chen J; Wang J
Oncol Lett; 2018 Sep; 16(3):2873-2880. PubMed ID: 30127874
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of the USO1 gene product which is essential for vesicular transport in Saccharomyces cerevisiae.
Seog DH; Kito M; Igarashi K; Yoda K; Yamasaki M
Biochem Biophys Res Commun; 1994 Apr; 200(1):647-53. PubMed ID: 8166741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
